|
Volumn 48, Issue 3, 2002, Pages 340-346
|
Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000;Rezul'taty lecheniia ostrogo limfoblastnogo leikoza u detei po protokolu Moskva-Berlin-91 v 1991-2000 gg.
a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
ASPARAGINASE;
CYTARABINE;
DAUNORUBICIN;
DEXAMETHASONE;
MERCAPTOPURINE;
METHOTREXATE;
VINCRISTINE;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CHILD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HUMAN;
INFANT;
MALE;
MORTALITY;
MULTICENTER STUDY;
PRESCHOOL CHILD;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
RISK FACTOR;
RUSSIAN FEDERATION;
STATISTICAL ANALYSIS;
SURVIVAL;
TIME;
6-MERCAPTOPURINE;
ADOLESCENT;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASPARAGINASE;
CHILD;
CHILD, PRESCHOOL;
CYTARABINE;
DATA INTERPRETATION, STATISTICAL;
DAUNORUBICIN;
DEXAMETHASONE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INFANT;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
MALE;
METHOTREXATE;
MOSCOW;
REMISSION INDUCTION;
RISK FACTORS;
RUSSIA;
SURVIVAL ANALYSIS;
TIME FACTORS;
VINCRISTINE;
|
EID: 0036047211
PISSN: 05073758
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|